학술논문
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Document Type
Conference Paper
Author
Source
In: Breast . (Breast, December 2023, 72)
Subject
Language
English
ISSN
15323080
09609776
09609776